Sivers has announced the resignation of CEO Anders Strom, who is leaving his position to pursue new ...
ChargePanel AB (”ChargePanel” eller ”Bolaget”) har under helåret 2023 uppvisat en hög aktivitet geno...
Redeye briefly comments on BeammWave's rights issue.
IRLAB Therapeutics has confirmed the FDA’s alignment with its proposed Phase III programme for mesdo...
Inga större ordrar under Q1’24 och tuffa jämförelsetal Under H1’24 möter MilDef tuffa jämförelsetal.
On Friday, TH1NG announced the divestment of its broadband customers to Bahnhof.
Redeye updates its estimates and fair value range following Energy Save’s Q3 2023/2024 report.
Adj. EBITDA of GBP 2m in line with pre-annoucement (ABGSCe 3m) We trim sales but raise '24e EBIT fro...
Redeye leaves a comment following the Magle Group’s announced public offer to acquire Amniotics earl...
FDA aligns with Ph 3 design presented at IRLAB's 2023 CMD Design compatible with earlier Ph 2b, to c...
Movinn published on March 22nd the company’s Annual Report for 2023.
Huddlestock announced on Friday, March 22nd, that the company's client Stackby.
Redeye comments on the public offer to acquire Amniotics and the short-term capital obtained yesterd...
Redeye provides its initial comments following Smart Eye’s directed share issue of SEK150m, announce...
Redeye provides a research update on Scandinavian ChemoTech following the Q4 2023 report and the ret...
Nytt obligationslån Vi återupptar vår bevakning av Orexo efter att bolaget emitterat ett nytt säkers...
Brilliant Future, med en kund- och medarbetarundersökningsplattform, ökade nettoomsättningen till 89...
A diversified M&A play on civic infrastructure 1) Rapid growth, 2) deleveraging, 3) 15% growth & 12%...
Redeye updates its view on Flexion Mobile following its Q4 2023 report.
FY'24 guidance reiterated as expected; better FCF the main surprise Progress on path to profitabilit...
